Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)

NCT03294434 is registered in ClinicalTrials.gov with CCTU- Cancer Theme as lead sponsor.

NCT NCT03294434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03294434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
Lead sponsor
CCTU- Cancer Theme
Phase
Observational
Overall status
Completed
Start date
March 2, 2017
Completion date
July 11, 2024
Enrollment
147 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high grade glioma